These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22160397)

  • 21. Vitamin D therapy in chronic kidney disease: back to the future?
    Damasiewicz MJ; Kerr PG; Polkinghorne KR
    Clin Nephrol; 2015 Aug; 84(2):65-74. PubMed ID: 26152127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Vitamin D in Uremic Vascular Calcification.
    Hou YC; Liu WC; Zheng CM; Zheng JQ; Yen TH; Lu KC
    Biomed Res Int; 2017; 2017():2803579. PubMed ID: 28286758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D and Glomerulonephritis.
    Gembillo G; Siligato R; Amatruda M; Conti G; Santoro D
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33671780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The application of vitamin D and its analogues in patients with chronic kidney disease: the Chinese practice program (2019)].
    Chinese Nephrologist Association, The Working Group of Chinese Practice Program of Vitamin D
    Zhonghua Nei Ke Za Zhi; 2020 Feb; 59(2):104-116. PubMed ID: 32074683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of renin-angiotensin system blockade in patients with chronic kidney disease under specialist care. Retrospective cross-sectional study.
    Tylicki L; Jakubowska A; Lizakowski S; Świetlik D; Rutkowski B
    J Renin Angiotensin Aldosterone Syst; 2015 Mar; 16(1):145-52. PubMed ID: 25324423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of renin-angiotensin-aldosterone system blockade in adults with diabetes mellitus and advanced chronic kidney disease not on dialysis: a systematic review and meta-analysis.
    Nistor I; De Sutter J; Drechsler C; Goldsmith D; Soler MJ; Tomson C; Wiecek A; Donciu MD; Bolignano D; Van Biesen W; Covic A
    Nephrol Dial Transplant; 2018 Jan; 33(1):12-22. PubMed ID: 29106631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D: a new hope for chronic kidney disease?
    Li M; Batuman V
    Kidney Int; 2009 Dec; 76(12):1219-21. PubMed ID: 19946310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibroblast growth factor 23 modifies the pharmacological effects of angiotensin receptor blockade in experimental renal fibrosis.
    de Jong MA; Mirkovic K; Mencke R; Hoenderop JG; Bindels RJ; Vervloet MG; Hillebrands JL; van den Born J; Navis G; de Borst MH;
    Nephrol Dial Transplant; 2017 Jan; 32(1):73-80. PubMed ID: 27220755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M; Komaba H; Fukagawa M
    Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation?
    Sarafidis PA; Ruilope LM
    Kidney Int; 2014 Mar; 85(3):536-46. PubMed ID: 24048382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Native vitamin D in pre-dialysis chronic kidney disease.
    Cardoso MP; Pereira LAL
    Nefrologia (Engl Ed); 2019; 39(1):18-28. PubMed ID: 30274806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revisiting RAAS blockade in CKD with newer potassium-binding drugs.
    Georgianos PI; Agarwal R
    Kidney Int; 2018 Feb; 93(2):325-334. PubMed ID: 29276100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Vitamin D in Vascular Complications and Vascular Access Outcome in Patients with Chronic Kidney Disease.
    Santoro D; Pellicanò V; Cernaro V; Lacava V; Lacquaniti A; Atteritano M; Buemi M
    Curr Med Chem; 2016; 23(17):1698-707. PubMed ID: 27048340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of RAAS Inhibitors in Patients with Kidney Disease.
    Zhang F; Liu H; Liu D; Liu Y; Li H; Tan X; Liu F; Peng Y; Zhang H
    Curr Hypertens Rep; 2017 Aug; 19(9):72. PubMed ID: 28791529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D in chronic kidney disease.
    Chau YY; Kumar J
    Indian J Pediatr; 2012 Aug; 79(8):1062-8. PubMed ID: 22544696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renoprotective effects of Vitamin D and renin-angiotensin system.
    Koroshi A; Idrizi A
    Hippokratia; 2011 Oct; 15(4):308-11. PubMed ID: 24391410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D in chronic kidney disease.
    Dusso A; González EA; Martin KJ
    Best Pract Res Clin Endocrinol Metab; 2011 Aug; 25(4):647-55. PubMed ID: 21872805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and prognostic implications of vitamin D deficiency in chronic kidney disease.
    Obi Y; Hamano T; Isaka Y
    Dis Markers; 2015; 2015():868961. PubMed ID: 25883412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment.
    Joy MS; Karagiannis PC; Peyerl FW
    J Manag Care Pharm; 2007 Jun; 13(5):397-411. PubMed ID: 17605511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical features of CKD-MBD in Japan: cohort studies and registry.
    Hamano T; Sakaguchi Y; Fujii N; Isaka Y
    Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):9-20. PubMed ID: 27942882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.